New to Moneycontrol - Sign up now
Its easy and FREE!
OR connect with
Don’t have an account?
10.31 am | 14 Feb 2013 | Source: CNBC-TV18
Biocon, a global biopharmaceutical enterprise today entered into a licencing agreement with Mylan for three bio-generic insulin products. Kiran Mazumd...
Facebook Twitter RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android